5-HT2C receptor involvement in female rat lordosis behavior

Amy Wolf, A Wolf, Marjay Caldarola-Pastuszka, M Caldarola-Pastuszka, Mini DeLashaw, M DeLashaw, L Uphouse, Lynda Uphouse
Brain research · 1999 · vol. 825(1-2) , pp. 146–151 · doi:10.1016/s0006-8993(99)01159-2 · PMID:10216181 · W2078568175
Lab / animal OA: closed CC0 ⤵ 1 in-corpus citation
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-08-07 ⓘ

The 5-HT2C receptor antagonist SB 206553 inhibited lordosis behavior, while the 5-HT2A antagonist MDL 100,907 did not, suggesting 5-HT2C receptors primarily mediate 5-HT2 receptor effects on female rat sexual receptivity.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Adult, hormone-primed, ovariectomized rats (CDF-344) with bilateral implants within the ventromedial nucleus of the hypothalamus (VMN), were injected with 0.5 microgram estradiol benzoate followed 48 h later with 500 microgram progesterone. This priming produced rats with 2 different levels of sexual receptivity. Rats with a lordosis to mount ratio (L/M)>/=0.5 were used to examine the potential lordosis-inhibiting effects of the 5-HT2A receptor antagonist, R(+)-a-(2, 3-dimethoxyphenyl)-1-[2(4-fluoro-phenylethyl)]-4-piperidine-methanol (MDL 100,907), and the 5-HT2C receptor antagonist, 5-methyl-1-(3-pyridylcarbamoyl)-1,2,3,5-tetrahydropyrrolo[2, 3-f]indole (SB 206553). Rats with low sexual receptivity (L/M<0.5) were bilaterally infused with the 5-HT2A/2C receptor agonist, (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane HCl (DOI), or DOI plus either MDL 100,907 or SB 206553 to determine if either drug would attenuate the lordosis-facilitating effects of DOI. The 5-HT2C receptor antagonist, but not the 5-HT2A receptor antagonist, effectively inhibited lordosis behavior. Similarly, SB 206553 was more effective than MDL 100,907 in reducing the DOI-induced increase in lordosis responding. However, both drugs limited the duration of lordosis responding initiated by DOI. These results are consistent with prior suggestions that 5-HT2A/2C receptors within the VMN are involved in the modulation of lordosis behavior and lead to the suggestion that 5-HT2C, rather than 5-HT2A, receptors are primarily responsible for the effects of 5-HT2 receptor-active drugs on lordosis behavior.

My notes (saved in your browser only)

MeSH descriptors

Posture Receptors, Serotonin Sexual Behavior, Animal Ventromedial Hypothalamic Nucleus Animals Estradiol Estradiol Estradiol Female Fluorobenzenes Fluorobenzenes Indoles Indoles Indophenol Indophenol Indophenol Ketanserin Ketanserin Ovariectomy Piperidines

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (2)

References (21)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T20:58:50.057178+00:00
unpaywall
last seen: 2026-10-19T06:34:38.229974+00:00
License: CC0 · commercial use OK